Susquehanna International Group
BNTX icon

Susquehanna International Group’s BioNTech BNTX Stock Holding History

Susquehanna International Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.2M Sell
373,400
-94,400
-20% -$9.7M ﹤0.01% 1636
2025
Q4 		$44.5M Buy
467,800
+70,400
+18% +$7.09M 0.01% 1460
2025
Q3 		$39.2M Buy
397,400
+3,300
+0.8% +$353K ﹤0.01% 1535
2025
Q2 		$42M Buy
394,100
+129,800
+49% +$13.1M 0.01% 1293
2025
Q1 		$24.1M Sell
264,300
-134,300
-34% -$15M ﹤0.01% 1577
2024
Q4 		$45.4M Buy
398,600
+60,900
+18% +$6.95M 0.01% 1199
2024
Q3 		$40.1M Buy
337,700
+111,600
+49% +$10.3M 0.01% 1238
2024
Q2 		$18.2M Sell
226,100
-237,800
-51% -$21.7M ﹤0.01% 1827
2024
Q1 		$42.8M Buy
463,900
+71,300
+18% +$6.84M 0.01% 1142
2023
Q4 		$41.4M Sell
392,600
-56,200
-13% -$5.66M 0.01% 1165
2023
Q3 		$48.8M Buy
448,800
+19,500
+5% +$2.16M 0.01% 1024
2023
Q2 		$46.3M Buy
429,300
+23,800
+6% +$2.68M 0.01% 1054
2023
Q1 		$50.5M Sell
405,500
-369,300
-48% -$50.7M 0.01% 937
2022
Q4 		$116M Buy
774,800
+57,700
+8% +$8.88M 0.03% 494
2022
Q3 		$96.7M Sell
717,100
-373,500
-34% -$57.1M 0.03% 507
2022
Q2 		$163M Sell
1,090,600
-292,300
-21% -$44.7M 0.04% 362
2022
Q1 		$236M Sell
1,382,900
-629,900
-31% -$106M 0.04% 350
2021
Q4 		$519M Sell
2,012,800
-824,900
-29% -$226M 0.08% 193
2021
Q3 		$775M Buy
2,837,700
+976,700
+52% +$310M 0.1% 139
2021
Q2 		$417M Buy
1,861,000
+442,100
+31% +$83.4M 0.06% 268
2021
Q1 		$155M Buy
1,418,900
+536,400
+61% +$57M 0.02% 552
2020
Q4 		$71.9M Sell
882,500
-542,800
-38% -$53.3M 0.01% 821
2020
Q3 		$98.7M Buy
1,425,300
+1,149,200
+416% +$82.4M 0.02% 572
2020
Q2 		$18.4M Buy
+276,100
New +$13.8M ﹤0.01% 1494

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group's BNTX Position: Q1 2026 in Review

Susquehanna International Group increased its BioNTech (BNTX) stake by 30% in Q1 2026, buying an estimated $4.55M and bringing the position to 193,461 shares worth $17.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2421.

Susquehanna International Group first reported a position in BNTX in Q2 2020 and has held it in 23 quarters since. The position peaked at $253M in Q3 2021. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Susquehanna International Group held 193,461 shares of BioNTech worth $17.2M as of Q1 2026.
  • Susquehanna International Group bought 44,237 BioNTech shares in Q1 2026, an estimated $4.55M.
  • BioNTech made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2421 holding.
  • Susquehanna International Group first reported a position in BioNTech in Q2 2020 and has held it in 23 quarters since.
  • Susquehanna International Group's BioNTech position peaked at $253M in Q3 2021.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.